Hinova pharmaceuticals usa inc

Author: sxfe

August undefined, 2024

Webb22 mars 2024 · Hinova Pharmaceuticals Inc is a Chinese company mainly engaged in the research and development of innovative drugs for critical illnesses. The Company focuses its research on the fields of tumor, metabolic diseases and other critical illnesses. The Company's research platforms include a deuterated drug development platform, a … Webb31 dec. 2024 · HINOVA PHARMACEUTICALS INC. (688302) Add to my list Report Summary Quotes Charts News Ratings Calendar Company Financials Consensus Revisions Funds Summary Most relevant All News Other languages Press Releases Official Publications Sector news All news about HINOVA PHARMACEUTICALS INC. …

SVP of medicinal chemistry - Hinova Pharmaceuticals …

WebbHinova is one of the fastest growing start-up drug discovery and development companies in China. In addition to HC-1119, which is in Phase III international multi-center trials for … WebbMELBOURNE, Australia, Jan. 20, 2024 /PRNewswire/ -- Hinova Pharmaceuticals Inc., a clinical-stage biopharmaceutical company focused on developing novel therapeutics for … micheline force am 2 29

Contact Us - Hinova Pharmaceuticals Inc.

Webb29 jan. 2024 · About us Hinova (688302.SH) is an international and clinical-stage pharmaceutical company focused on developing new therapeutics for cancers and … WebbHinova Pharmaceuticals Inc is a Chinese company mainly engaged in the research and development of innovative drugs for critical illnesses. The Company focuses its research on the fields of tumor, metabolic diseases and other critical illnesses. WebbUnique Protocol ID: HP518-CS-001 : Brief Title: A Study to Assess the Safety, Pharmacokinetics, and Anti-Tumor Activity of Oral HP518 in Patients With Metastatic Castration-Resistant Prostate Cancer micheline hammouda

HINOVA PHARMACEUTICALS INC. : Stock Market News and …

Hinova Pharmaceuticals Inc. (688302.SS) - Yahoo Finance

Webb27 feb. 2024 · Hinova Pharmaceuticals Inc. reported earnings results for the full year ended December 31, 2024. For the full year, the company reported sales was CNY 1.65 million. Net loss was CNY 301.51 million compared to CNY 306.18 million a year ago. Basic loss per share from continuing operations was CNY 3.27 compared to CNY 4.12 … Webb31 dec. 2024 · End-of-day quote Shanghai Stock Exchange - 2024-03-30. 53.99. CNY. -0.53%. 02/27. Hinova Pharmaceuticals Inc. Reports Earnings Results for the Full Year Ended December 31, 2024. CI. 02/10. Hinova Pharma Gets Regulatory Nod for Anti-Tumor Drug Trial. micheline goulartWebb11 apr. 2024 · About the Company. Hinova Pharmaceuticals Inc. engages in the development and production of drugs in the therapeutic areas of tumors and metabolic diseases. It develops drugs based on technology platforms, such as deuterium and PROTAC. The company’s products in pipeline include HC-1119, a product in Phase III … micheline gary - meurisse

"Webb海创药业是一家基于PROTAC靶向蛋白降解和氘代药物研发等技术平台，以开发具有重大临床需求的Best-in-class、First-in-class药物为目标的国际化创新药企业。公司专注于肿 … " - Hinova pharmaceuticals usa inc

Hinova pharmaceuticals usa inc

Webb1 aug. 2024 · Hinova Pharmaceuticals Inc is an international drug company based on technology platforms such as deuterium and PROTAC, Drug Discovery. Chengdu, China. 113 As of 2024 ... US-20240027088-A1: Ep300/cbp inhibitor: Pending: 27-Sep-2024: 0000000000: EP-4019510-A1: Halogen-substituted phenylate compound and … Webb31 dec. 2024 · HINOVA PHARMACEUTICALS INC. : Shareholders Board Members Managers and Company Profile CNE1000059F5 MarketScreener Homepage Equities China Shanghai Stock Exchange Hinova Pharmaceuticals Inc. Company 688302 CNE1000059F5 HINOVA PHARMACEUTICALS INC. (688302) Add to my list Report …

Did you know?

WebbHP558 is a First-in-class CD44v6 inhibitor developed by German pharmaceutical company Amcure GmbH. Phase I clinical trial was completed in Europe. HP558 could be used as … WebbHINOVA PHARMACEUTICALS (USA) INC. was registered on 04 Dec 2024 as Foreign Stock company type incorporated at 5405 MOREHOUSE DR STE 320, SAN DIEGO, CA 92121. The agent name of this company is: YING LIU ,and company's status is Active .

WebbCompany Description: Hinova Pharmaceuticals, Inc. is located in Houston, TX, United States and is part of the Management, Scientific, and Technical Consulting Services …

Webbför 8 timmar sedan · Currently, Foresee Pharmaceuticals and Myovant Biosciences are leading the therapeutics market with their Metastatic Prostate Cancer drug candidates in the most advanced stages of clinical... WebbGet the latest Hinova Pharmaceuticals Inc (688302) real-time quote, historical performance, charts, and other financial information to help you make more informed …

Webb23 feb. 2024 · Hinova Pharmaceuticals Aus Pty Ltd: ClinicalTrials.gov Identifier: NCT05252364 Other Study ID Numbers: HP518-CS-001 : First Posted: February 23, …

WebbHINOVA PHARMACEUTICALS (USA) INC. is a California Stock Corporation - Out Of State - Stock filed on December 4, 2024. The company's filing status is listed as Active and its File Number is 4217214. The Registered Agent on file for this company is Ying Liu and is located at 5405 Morehouse Dr Ste 320, San Diego, CA 92121. the new shoes 2016WebbHinova pharma is an international pharmaceutical company engaged in the development of innovative Best-in-class and First-in-class PROTAC and deuterated drugs. Hinova … U.S.A Hinova (USA) Address: 300 Delaware Avenue, Suite 210-A, … Working at Hinova Employee Benefits Open Positions Build a leading … micheline hair salon collingwoodWebbFounded Date 2013. Founders Xinghai Li, Yuanwei Chen. Operating Status Active. Last Funding Type Series C. Also Known As Haichuang Pharmaceutical , 海创药业, Haichuang Yaoye, 成都海创药业有限公司. Legal Name Hinova Pharmaceuticals Inc. Company Type For Profit. Phone Number (028) 8505 8465. Hinova Pharma is an innovative drug ... the new shoes of messiWebb31 dec. 2024 · Hinova Pharmaceuticals Inc. Ratings 688302 CNE1000059F5 HINOVA PHARMACEUTICALS INC. (688302) Add to my list Report Summary Quotes Charts News Ratings Calendar Company Financials Consensus Revisions Funds Financials Valuation Momentum Turnover review 12m Turnover review 4m Turnover review 7 days Earnings … micheline holmes crnpWebb31 dec. 2024 · Hinova Pharmaceuticals Inc is a Chinese company mainly engaged in the research and development of innovative drugs for critical illnesses. The Company … micheline hollaus interiorsWebbHsk3486 - Haisco-USA Pharmaceutical Company, Inc. HSK3486 Product Profile Mechanism of Action: The primary mechanism of action for HSK3486 is to increase chloride ion influx through the gamma-aminobutyric acid receptor subtype A (GABAᴀ)-mediated ion channels to achieve central nervous system (CNS) depression the new shoe store tunkhannockWebbHinova Pharmaceuticals Inc. Headquarters: Chengdu, China Website: http://www.hinovapharma.com Year Founded: 2013 Status: Private BioCentury Jan 10, 2024 Financial News Jan. 9 Financial Quick Takes: Closes for two royalty funds; plus Apellis leads follow-on trio, Element, Omniome, Hinova, Emergex, Tscan, Calliditas micheline gallagher